| By PR Newswire | Article Rating: |
|
| November 13, 2012 01:17 PM EST |
BALA CYNWYD, Pa., Nov. 13, 2012 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Jefferies Group, Inc. ("Jefferies" or the "Company") (NYSE: JEF) relating to the proposed acquisition by Leucadia National Corporation, Inc. ("Leucadia").
Under the terms of the transaction, Jefferies shareholders will receive only 0.81 shares of Leucadia stock for each share of Jefferies stock they own. The transaction values Jefferies stock at approximately $17.24. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Jefferies for not acting in the Company's shareholders' best interests in connection with the sale process to Leucadia. The transaction may undervalue the Company and will result in a loss many Jefferies shareholders. For example Jefferies stock traded at $26.84 on January 14, 2011 and $19.45 as recently as March 26, 2012. In addition, an analyst has set a price target for Jefferies stock at $19.00 per share.
If you own shares of Jefferies stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com visiting http://brodsky-smith.com/503-jef-jefferies-group-inc.html, by calling toll free 877-LEGAL-90.
SOURCE Brodsky & Smith, LLC
Published November 13, 2012
Copyright © 2012 SYS-CON Media, Inc. — All Rights Reserved.
Syndicated stories and blog feeds, all rights reserved by the author.
More Stories By PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

